Transphorm, Inc.

NASDAQ:TGAN

5.1 (USD) • At close June 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Revenue 16.51124.0511.37111.9340
Cost of Revenue 17.46112.536.6826.4920
Gross Profit -0.9511.524.6895.4420
Gross Profit Ratio -0.0580.4790.4120.4560
Reseach & Development Expenses 8.9086.6555.5848.1460
General & Administrative Expenses 13.67211.22610.3286.6060
Selling & Marketing Expenses 5.2473.5352.1742.6090
SG&A 18.91914.76112.5029.2150
Other Expenses 1.6333.8193.0841.097-0.044
Operating Expenses 27.82721.41618.08617.361-0.044
Operating Income -28.777-9.896-13.397-11.919-0.044
Operating Income Ratio -1.743-0.411-1.178-0.9990
Total Other Income Expenses Net -1.821-0.339-4.512-3.3640
Income Before Tax -30.598-10.235-17.909-15.283-0.044
Income Before Tax Ratio -1.853-0.426-1.575-1.2810
Income Tax Expense 1.0910.3394.5123.3640
Net Income -31.689-10.574-22.421-18.647-0.044
Net Income Ratio -1.919-0.44-1.972-1.5630
EPS -0.56-0.23-0.71-0.530
EPS Diluted -0.56-0.23-0.71-0.530
EBITDA -28.334-8.601-16.314-13.309-0.044
EBITDA Ratio -1.716-0.358-1.435-1.1150